CGL
Clarius Group LLC Portfolio holdings
AUM
$1.72B
This Quarter Return
-0.24%
1 Year Return
+14.66%
3 Year Return
+85.31%
5 Year Return
+125.74%
10 Year Return
–
AUM
$545M
AUM Growth
+$545M
(+9.6%)
Cap. Flow
+$52.6M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
54.6%
Holding
288
New
25
Increased
188
Reduced
44
Closed
10
Top Buys
Top Sells
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$1.54M |
| 2 |
Impinj
PI
|
$1.11M |
| 3 |
Vanguard Growth ETF
VUG
|
$448K |
| 4 |
Vanguard Value ETF
VTV
|
$431K |
| 5 |
DATA
Tableau Software, Inc.
DATA
|
$363K |
Sector Composition
| 1 | Industrials | 18.83% |
| 2 | Technology | 17.35% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Financials | 5.43% |
| 5 | Communication Services | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Estee Lauder
EL
$33B
| $282K | 0.05% |
1,416
+239
| +20% | +$47.6K |
|
202
Capital One
COF
$145B
| $278K | 0.05% |
3,058
+194
| +7% | +$17.6K |
|
203
Diageo
DEO
$62.1B
| $277K | 0.05% |
1,697
+292
| +21% | +$47.7K |
|
204
Valero Energy
VLO
$47.2B
| $277K | 0.05% |
3,254
-245
| -7% | -$20.9K |
|
205
Expeditors International
EXPD
$16.4B
| $276K | 0.05% |
3,712
+23
| +0.6% | +$1.71K |
|
206
AstraZeneca
AZN
$248B
| $274K | 0.05% |
+6,138
| New | +$274K |
|
207
GSK
GSK
$79.9B
| $274K | 0.05% |
6,412
+822
| +15% | +$35.1K |
|
208
Equinix
EQIX
$76.9B
| $267K | 0.05% |
463
+44
| +11% | +$25.4K |
|
209
iShares Core Conservative Allocation ETF
AOK
$631M
| $265K | 0.05% |
7,431
-7,846
| -51% | -$280K |
|
210
Exelon
EXC
$44.1B
| $265K | 0.05% |
5,495
+934
| +20% | +$45K |
|
211
VF Corp
VFC
$5.91B
| $263K | 0.05% |
2,953
+315
| +12% | +$28.1K |
|
|
WBA
212
DELISTED
Walgreens Boots Alliance
WBA
| $262K | 0.05% |
4,729
+896
| +23% | +$49.6K |
|
213
Workday
WDAY
$61.6B
| $262K | 0.05% |
1,542
+200
| +15% | +$34K |
|
214
Progressive
PGR
$145B
| $261K | 0.05% |
3,378
+260
| +8% | +$20.1K |
|
215
Sherwin-Williams
SHW
$91.2B
| $261K | 0.05% |
+474
| New | +$261K |
|
|
AGN
216
DELISTED
Allergan plc
AGN
| $261K | 0.05% |
+1,548
| New | +$261K |
|
217
Biogen
BIIB
$19.4B
| $260K | 0.05% |
1,115
+183
| +20% | +$42.7K |
|
|
DFS
218
DELISTED
Discover Financial Services
DFS
| $260K | 0.05% |
3,212
+49
| +2% | +$3.97K |
|
219
Idexx Laboratories
IDXX
$51.8B
| $258K | 0.05% |
949
+69
| +8% | +$18.8K |
|
220
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $258K | 0.05% |
+4,807
| New | +$258K |
|
221
Okta
OKTA
$16.4B
| $257K | 0.05% |
2,610
| – | – |
|
222
Paychex
PAYX
$50.2B
| $257K | 0.05% |
3,104
-81
| -3% | -$6.71K |
|
223
Global Payments
GPN
$21.5B
| $256K | 0.05% |
+1,611
| New | +$256K |
|
224
Emerson Electric
EMR
$74.3B
| $255K | 0.05% |
3,821
+258
| +7% | +$17.2K |
|
225
Sanofi
SNY
$121B
| $252K | 0.05% |
+5,449
| New | +$252K |
|